448 related articles for article (PubMed ID: 26942627)
1. Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery.
Kuppast B; Fahmy H
Eur J Med Chem; 2016 May; 113():198-213. PubMed ID: 26942627
[TBL] [Abstract][Full Text] [Related]
2. Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery.
Keshari AK; Singh AK; Saha S
Mini Rev Med Chem; 2017; 17(15):1488-1499. PubMed ID: 28215139
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel thiazolo[4,5-d]pyrimidine derivatives for antimicrobial, anti-HIV and anticancer investigation.
Rida SM; Habib NS; Badawey EA; Fahmy HT; Ghozlan HA
Pharmazie; 1996 Dec; 51(12):927-31. PubMed ID: 8985982
[TBL] [Abstract][Full Text] [Related]
4. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic advancement of benzothiazole derivatives in the last decennial period.
Tariq S; Kamboj P; Amir M
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800170. PubMed ID: 30488989
[TBL] [Abstract][Full Text] [Related]
6. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
Abdellatif KRA; Bakr RB
Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
[TBL] [Abstract][Full Text] [Related]
7. Application of Fluorine in Drug Design During 2010-2015 Years: A Mini-Review.
Wang BC; Wang LJ; Jiang B; Wang SY; Wu N; Li XQ; Shi DY
Mini Rev Med Chem; 2017; 17(8):683-692. PubMed ID: 26471967
[TBL] [Abstract][Full Text] [Related]
8. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of new heterocyclic structures: [1,3]thiazino[2,3-i]purine, thiazolo[3,2-c] [1,2,3]triazolo[4,5-e]pyrimidine and [1,2,3]triazolo [4', 5': 4,5] pyrimido[6,1-b][1,3]thiazine.
Rinaldi M; Pecorari P; Costantino L; Provvisionato A; Malagoli M; Cermelli C
Farmaco; 1992 Oct; 47(10):1315-22. PubMed ID: 1482518
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-imino and 2-hydrazono thiazolo[4,5-d]pyrimidines as corticotropin releasing factor (CRF) antagonists.
Teleb M; Kuppast B; Spyridaki K; Liapakis G; Fahmy H
Eur J Med Chem; 2017 Sep; 138():900-908. PubMed ID: 28750312
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.
Kuppast B; Spyridaki K; Lynch C; Hu Y; Liapakis G; Davies GE; Fahmy H
Med Chem; 2014; 11(1):50-9. PubMed ID: 25059547
[TBL] [Abstract][Full Text] [Related]
12. Key Updates on the Chemistry and Biological Roles of Thiazine Scaffold: A Review.
Choudhary S; Silakari O; Singh PK
Mini Rev Med Chem; 2018; 18(17):1452-1478. PubMed ID: 29663882
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d]pyrimidines.
Singh B; Guru SK; Kour S; Jain SK; Sharma R; Sharma PR; Singh SK; Bhushan S; Bharate SB; Vishwakarma RA
Eur J Med Chem; 2013; 70():864-74. PubMed ID: 24262379
[TBL] [Abstract][Full Text] [Related]
14. Thiazolopyrimidine Scaffold as a Promising Nucleus for Developing Anticancer Drugs: A Review Conducted in Last Decade.
Islam MR; Fahmy H
Anticancer Agents Med Chem; 2022; 22(17):2942-2955. PubMed ID: 35410622
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the chemistry and biology of pyridopyrimidines.
Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of certain new thiazolopyrimidines.
el-Bendary ER; el-Sherbeny MA; Badria FA
Boll Chim Farm; 1998 Apr; 137(4):115-9. PubMed ID: 9618969
[TBL] [Abstract][Full Text] [Related]
17. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
[TBL] [Abstract][Full Text] [Related]
19. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues.
Al-Omary FA; Hassan GS; El-Messery SM; El-Subbagh HI
Eur J Med Chem; 2012 Jan; 47(1):65-72. PubMed ID: 22056277
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
Abu-Hashem AA; Gouda MA; Badria FA
Eur J Med Chem; 2010 May; 45(5):1976-81. PubMed ID: 20149490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
